Commercial Amino Acids

Commercial Amino Acids

  • February 2014
  • 213 pages
  • BCC Research
Report ID: 109212

The U.S amino acids market reached $1.5 billion in 2012. This market is expected to grow to nearly $1.6 billion in 2013 and nearly $2 billion in 2018, a compound annual growth rate (CAGR) of 4.5%.

This report provides:
An overview of the market for amino acids
Analyses of market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
Identification of those amino acids with current or potentially greater commercial significance
A look at how new production technology continues to make large-scale production of these products more economical
Comprehensive profiles of leading companies in the industry.


This technical/marketing report updates a previous BCC Research study on commercial essential amino acids. Further, this study examines the current state of the commercial essential amino acid business, presents an in-depth analysis that forecasts and tracks significant change in the marketplace and identifies those amino acids with current or potentially greater commercial significance.


Commercial interest in amino acids is an outgrowth of an understanding of the many functions that these life-giving substances perform in humans and animals. As understanding of the functions and properties of amino acids increases, new commercial applications enter development, while current commercial uses continue to expand their worldwide markets. New production technology continues to make large-scale production of these products more economical. In turn, increased availability creates newer and larger markets for these vital substances.Amino acids gained commercial significance shortly after the turn of the century with the discovery of the flavor-enhancing quality of glutamic acid and the marketing of monosodium glutamate in Japan. Increased knowledge of the role amino acids play in the value of nutritional protein led to their being used to fortify animal feeds, as food supplements for humans and to sustain seriously ill patients who had to be fed with intravenous solutions.Since the 20 protein amino acids can be arranged in any order to make any number of polypeptides, their potential for a variety of inventions in the field of medicine is extraordinary. Their current uses in animal feed and food additives will continue to grow as there are no substitutes for amino acids and their value has been well proven.


This comprehensive study provides facts, data and insights to senior market and planning executives, venture capitalists and for the amino acid product interest community. It will assist manufacturers of products in any of the applicable markets, as well as technical personnel involved in research and development of production technology for commercial amino acids. This especially includes readers in:
The chemical industry.
Research institutions involved with studying amino acids.
Amino acid manufacturing.
Industries that have amino acid by-products.


This technical/market report outlines the properties of the 20 commercial essential amino acids that are delineated in the genetic code, current and future uses, technology and their manufacturers. This report focuses on three commercial amino acid markets: animal feed supplements, flavoring and nutritional additives for human food and specialty uses, including medical, therapeutic, research and industrial applications. Feed and food applications offer steady growth opportunities to their manufacturers and their use will continue to grow as a result of both population increases and an overall increase in the worldwide standard of living.


Both primary and secondary research methodologies were used in preparing this study. Much of the information has been gathered through telephone conversations with key industry figures, as well as conversations with some of the academic experts in amino acid research. The balance of the information comes from secondary sources—available trade, technical and government publications as well as an online data search of databases that cover all existing literature, and an evaluation of patents and company/research activities, including foreign work with future applicability in the U.S.All value of shipments and value of manufacturers' sales refer to specific markets in the U.S. international figures are given where appropriate. Volume and value figures are expressed in millions of pounds and millions of dollars unless otherwise indicated. All figures are expressed in constant 2013 U.S. dollars. To make projections for the 2018 time period, the report relies on information regarding forces affecting specific markets, expected product introductions and anticipated pricing.Where precise information was not forthcoming in some cases, a consensus was reached using a formulation of reasonable assumptions and estimates based on historical data. Projections are for the 2013 to 2018 time period.
Country=UnitedStates Industry=OTC ParentIndustry=Pharmaceutical Date=201402 Topic=MarketReport Publisher=BCCResearch Price=5000